Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/OH/Youngstown
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Youngstown, OH

Studies commonly pay $75 to $4,500 per completed study

89 clinical trials are currently recruiting participants within 30 miles of Youngstown. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

89studies recruiting
3+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Youngstown right now

Top 25 of 89 recruiting studies, sorted by proximity — each links to its official registry page

Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy

Autophagy, Healthy Aging N/A Interventional 70 participants sought
The Center for Applied Health Sciences — Canfield, Ohio (7.9 mi) · Sponsor: Nutraland USA, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07675200)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04671667)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Breast Cancer, Early Breast Cancer Phase 3 Interventional 4,300 participants sought
Research Site — Youngstown, Ohio (0.2 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT05774951)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Aultman Alliance Community Hospital — Alliance, Ohio (27.1 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06418204)

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Phase 2 Interventional 180 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07195734)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05896189)

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Extensive Stage Lung Small Cell Carcinoma Phase 2, Phase 3 Interventional 138 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04402788)

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee

Osteoarthritis Phase 2 Interventional 4,000 participants sought
VivaTech International, Inc. — Grove City, Pennsylvania (29.3 mi) · Sponsor: VivaTech International, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT02844751)

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain Phase 3 Interventional 200 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04804644)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06876714)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,000 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05334069)

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Phase 2 Interventional 240 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05327686)

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder

Osteoarthritis Phase 2 Interventional 4,000 participants sought
VivaTech International, Inc. — Grove City, Pennsylvania (29.3 mi) · Sponsor: VivaTech International, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT02844738)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Multiple conditions Phase 2 Interventional 314 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT03866382)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05946213)

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 3 Interventional 382 participants sought
Saint Elizabeth Youngstown Hospital — Youngstown, Ohio (0.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05677490)

Interrater Reliability and Feasibility of the Lasater Clinical Judgment Rubric for Use in Physical Therapy Simulation

Physical Therapy Education, Clinical Judgement Assessment N/A Observational 40 participants sought
Youngstown State University — Youngstown, Ohio (0.2 mi) · Sponsor: Youngstown State University
See eligibility & contact on ClinicalTrials.gov (NCT07449026)

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Phase 2 Interventional 66 participants sought
UPMC Cancer Center at UPMC Horizon — Farrell, Pennsylvania (11.0 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05642572)

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 2, Phase 3 Interventional 224 participants sought
UPMC Hillman Cancer Center - New Castle — New Castle, Pennsylvania (16.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06203600)
Google-rated

Top-rated research centers in Youngstown

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

The Center for Applied Health Sciences

★ 5.0
6570 Seville Dr, Canfield, OH 44406
(330) 926-6927

Integrity First Clinical Trials

400 E Main St Ste M3, Canfield, OH 44406
(330) 234-9416

Optima Research

1039 Boardman-Canfield Rd Bldg B, Suite B, Boardman, OH 44512
(330) 422-3234

Clinical trials in Youngstown: what's recruiting

The Youngstown area currently has 89 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Youngstown, the most active research areas are:

  • Cancer & Oncology20 studies
  • Liver & Kidney3 studies
  • Immune & Skin2 studies

Every listing shows the study phase, the recruiting site and its distance from Youngstown, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Youngstown

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Youngstown participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Youngstown?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Youngstown, OH?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Youngstown?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Youngstown?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Youngstown.

Paid clinical trials near Youngstown

Other metros within reach

Canton, OH314 Akron, OH398 Pittsburgh, PA1,236 Cleveland, OH1,419 Erie, PA91 Lorain, OH1,313 Buffalo, NY520 Columbus, OH1,325

More of OH

Cleveland1,419 Columbus1,325 Lorain1,313 Cincinnati1,137 Akron398 Canton314 Dayton309 Toledo209

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts